Differential Expression of Salivary Transcriptomic Biomarkers SAT1 and PSMB2 in Type 2 Diabetes Mellitus: A Case–Control Study
Differenzielle Expression der salivären transkriptomischen Biomarker SAT1 und PSMB2 bei Diabetes mellitus Typ 2: Fall-Kontroll-Studie
Contemporary Clinical Dentistry · 2026-07 · 17 (3) · 192-196
DOI: 10.4103/ccd.ccd_225_26 ↗Auf einen Blick
In einer Fall-Kontroll-Studie waren SAT1 und PSMB2 in Speichelproben von Personen mit Diabetes mellitus Typ 2 verändert. PSMB2 unterschied sich statistisch signifikant zwischen den Gruppen.
Fragestellung
Unterscheidet sich die relative Genexpression der salivären Biomarker SAT1 und PSMB2 bei Personen mit Diabetes mellitus Typ 2 gegenüber gesunden Kontrollen?
Methode
Fall-Kontroll-Studie mit 2 Gruppen; 50 Teilnehmende pro Gruppe. Unstimulierte Speichelproben; Genexpression per real-time PCR und 2-ΔΔCT-Methode.
Ergebnisse
SAT1 war bei T2DM um 54 % herunterreguliert, Fold-Change 0.46. PSMB2 war bei T2DM gegenüber Kontrollen herunterreguliert. PSMB2 zeigte einen statistisch signifikanten Unterschied (P < 0.05), SAT1 nicht.
Schlussfolgerung der Autor:innen
Die Analyse der Genexpression von SAT1 und PSMB2 im Speichel von T2DM-Patient:innen könnte die Entwicklung einer nichtinvasiven Frühdiagnostik zur frühen Intervention unterstützen.
Kernaussagen
- Speichelbasierte Biomarker SAT1 und PSMB2 wurden bei T2DM untersucht.
- SAT1 war um 54 % herunterreguliert, Fold-Change 0.46.
- PSMB2 zeigte einen statistisch signifikanten Unterschied (P < 0.05).
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Dentistry, online erschienen am 22.09.2026. Verfasst von Nalini Aswath und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine and Radiology, Sree Balaji Dental College and Hospital, Chennai, Tamil Nadu, India. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is the most common underdiagnosed metabolic disease due to lack of recognizable symptoms in the early phase. T2DM often goes undetected for years, leading to high rates of complications and mortality. RNA signatures in saliva could serve as valid, noninvasive biomarker for the detection of T2DM with high sensitivity and specificity.
Aim
To analyze the relative gene expression of salivary transcriptomic biomarkers SAT1 and PSMB2 in individuals with T2DM. Settings and Design: This case–control study included two groups: age- and sex-matched T2DM patients and healthy controls, with 50 participants in each group. Subjects and Methods: Unstimulated saliva samples were collected from all participants. Relative gene expression levels of salivary transcriptomic biomarkers, such as SAT1 and PSMB2 were analyzed using real-time polymerase chain reaction. The messenger RNA expression levels and fold changes were calculated using 2-ΔΔCT method. Statistical Analysis: Student’s t -test was applied to check the P value significance ( P < 0.05).
Results
The SAT1 gene was found to be downregulated by 54%, with a fold change of 0.46 in T2DM compared to controls, while PSMB2 was downregulated in T2DM when compared to healthy controls. Among the two biomarkers, PSMB2 showed a statistically significant difference ( P < 0.05), whereas SAT1 did not attain statistical significance.
Conclusion
Our study demonstrated that analysis of the genetic expression of salivary transcriptomic biomarkers SAT1 and PSMB2 genes in the saliva of T2DM patients might help in the development of a noninvasive early diagnostic aid to facilitate early intervention of T2DM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Medicine and Radiology, Sree Balaji Dental College and Hospital, Chennai, Tamil Nadu, India.
- Department of Human Genetics Research Centre, Sree Balaji Dental College and Hospital, Chennai, Tamil Nadu, India.
Zitieren
APA
Aswath, N., Subbiah, U., Subbiah, H. V., Ajith, A., & Mookkandi, S. (2026). Differential Expression of Salivary Transcriptomic Biomarkers SAT1 and PSMB2 in Type 2 Diabetes Mellitus: A Case–Control Study. Contemporary Clinical Dentistry, 17(3), 192-196. https://doi.org/10.4103/ccd.ccd_225_26
Vancouver
Aswath N, Subbiah U, Subbiah HV, Ajith A, Mookkandi S. Differential Expression of Salivary Transcriptomic Biomarkers SAT1 and PSMB2 in Type 2 Diabetes Mellitus: A Case–Control Study. Contemporary Clinical Dentistry. 2026;17(3):192-196. doi:10.4103/ccd.ccd_225_26
BibTeX
@article{Aswath2026,
author = {Aswath, Nalini and Subbiah, Usha and Subbiah, Harini Venkata and Ajith, Athira and Mookkandi, Sudhan},
title = {Differential Expression of Salivary Transcriptomic Biomarkers SAT1 and PSMB2 in Type 2 Diabetes Mellitus: A Case–Control Study},
journal = {Contemporary Clinical Dentistry},
year = {2026},
volume = {17},
number = {3},
pages = {192--196},
doi = {10.4103/ccd.ccd_225_26}
}
EUVIMED